Two Dividend ETFs Quietly Beating SCHD on Total Return Since 2022

The article compares dividend ETFs: SCHD delivered a 52.21% cumulative total return from Feb 2022–Jul 2, 2026 (expense ratio 0.06%, 30-day SEC yield 3.33%), but its ~42% annual turnover can create “boom/bust” outcomes. Fidelity’s FDVV returned 83.72% over the same period (expense ratio 0.15%, 30-day SEC yield 2.73%), and Capital Group’s CGDV returned 112.63% (expense ratio 0.33%, 30-day SEC yield 1.32%) with lower turnover (24%) and greater concentration (52 stocks). Overall message: SCHD remains attractive on yield/tax efficiency, while FDVV/CGDV have outperformed due largely to heavier large-cap tech exposure and/or active stock selection.

Analysis

The important signal is not “dividend investing is back,” but that income capital is migrating toward balance-sheet compounders with embedded tech beta. That creates a persistent marginal bid for MSFT, NVDA, AVGO, AAPL, GOOGL and META because they now sit inside both growth and income allocation sleeves, which should dampen drawdowns versus names owned only by pure-growth funds.

In the next 1-3 months, the catalyst is flow-driven: advisor model rebalances, ETF screeners, and performance-chasing into total-return funds that look defensive on paper but behave like quality-growth. The beneficiaries are the mega-cap platforms; the losers are traditional high-yield sectors that dominate classic dividend baskets, especially if rates stay range-bound and investors keep prioritizing dividend growth over headline yield. A falsifier is a broad factor rotation back into value, banks, energy, and staples, which would restore SCHD-style leadership quickly.

The consensus is missing that these products are really a proxy for owning AI winners inside an income wrapper, not a better yield product. That makes the move underappreciated for long-only portfolios but potentially overdone for yield-focused allocators; if dividend payers are valued on payout plus buybacks, the premium is justified, but if tech capex normalizes or free-cash-flow growth slows, the relative edge should fade over 6-18 months.

Key Decisions for Investors

• Long MSFT/AVGO/NVDA basket vs short SCHD for 3-6 months; highest conviction way to express the shift from static yield to dividend-growth compounders.
• Prefer CGDV or FDVV over SCHD in income sleeves on pullbacks; target 2-4% better total return over the next 12 months if mega-cap tech leadership persists.
• Use QQQ as the cleaner liquid proxy for the same rotation and buy on weakness; thesis breaks if value leadership returns and QQQ underperforms SCHD by >3% over a month.
• If 10-year yields fall and breadth improves, trim any overweight in CGDV/FDVV and rotate into SCHD or VIG; that regime would reduce the relative advantage of tech-heavy dividend funds.